Jill Howe

Jill Howe

Finansdirektör/CFO på ASTERIAS BIOTHERAPEUTICS INC

Förmögenhet: 33 915 $ per 2026-05-31

50 år
Health Technology
Consumer Services
Health Services

Profil

Jill Ann Howe is currently Director at MUSC Foundation for Research Development, Independent Director at Biora Therapeutics, Inc. since 2021, Chief Financial Officer at Lineage Cell Therapeutics, Inc. since 2022, and Chief Financial Officer at Asterias Biotherapeutics, Inc. Former positions include Director at Codagenix, Inc. from 2021 to 2025, Finance Director & Controller at Amplyx Pharmaceuticals, Inc. from 2016 to 2017, Finance Director & Controller at Somaxon Pharmaceuticals, Inc. from 2006 to 2013, Finance Director & Controller at Receptos LLC from 2013 to 2016, Chief Financial Officer at DTx Pharma, Inc. from 2021 to 2022, and Treasurer & VP-Finance at Gossamer Bio, Inc. from 2018 to 2021.
Education includes undergraduate studies at San Diego State University.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2026-04-20 25 500 ( 0,01 % ) 33 915 $ 2026-05-31

Aktiva positioner av Jill Howe

FöretagPositionStart
BIORA THERAPEUTICS, INC. Direktör/Styrelseledamot 2021-11-03
LINEAGE CELL THERAPEUTICS, INC. Finansdirektör/CFO 2022-11-14
ASTERIAS BIOTHERAPEUTICS INC Finansdirektör/CFO -
MUSC Foundation for Research Development
Direktör/Styrelseledamot -

Tidigare kända positioner av Jill Howe

FöretagPositionSlut
Direktör/Styrelseledamot 2025-03-01
Finansdirektör/CFO 2022-07-01
GOSSAMER BIO, INC. Treasurer 2021-06-01
Finansdirektör/CFO 2017-12-01
RECEPTOS INC Finansdirektör/CFO 2016-03-01
Se detaljerna i Jill Howes erfarenhet

Jill Howes utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

52

Första gradens relationer

11

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag11

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

MUSC Foundation for Research Development

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

- 40% : De bästa verktygen för abonnenter som vill hitta morgondagens bästa investeringar!
d
:
:
TA FÖRDEL AV DET NU